Person Image

    Education

    • วท.บ.(เคมี), มหาวิทยาลัยเกษตรศาสตร์, ไทย, 2543
    • ปร.ด.(เคมี), มหาวิทยาลัยเกษตรศาสตร์, ไทย, 2549

    Expertise Cloud

    (+)-Calanolide A3D-QSARAbsorptionAcetylcholinesteraseAcetylcholinesterase inhibitorAlzheimerAlzheimer’s diseaseantibacterial activityAnti-cancerAntitubercular AgentsAnti-tuberculosis agentsarticleArylamideATP-ase activityATPasesAzanaphthoquinoneBinding energyBinding sitesBioinformaticsBiological assaysBreast CancerCaco-2 cell lineCalloselasma rhodostomachemistrychitosanCOVID-19Crystal structureCytotoxicityDAPYdengue virusdensity functional theoryDipalmitoylphosphatidylcholine (DPPC)DNADNA gyrasesdockingenoyl-ACP reductaseFluoroquinolonesGOLD dockingHIV-1HIV-1 Reverse TranscriptaseHIV-1 RTHQSARhumanhuman serum albuminHumansHydrogen bondsHydrophobicityInhAInhA inhibitorligandM. tuberculosisMangifera indica L.MD SimulationMD simulationsMM-GBSAMM-PBSAMolecular dockingMolecular Docking SimulationMolecular docking studyMolecular dynamicsMolecular Dynamics Simulationmolecular dynamics simulationsMolecular modelingMycobacterium tuberculosisNaja naja kaouthiaN-benzylpyridiniumNNRTInonhumanONIOMPentagalloylglucopyranosePolyphenolsproteaseProtein kinase BQM/MMQSARquantum chemical calculationsretinolsilksimulationTuberculosistuberculostatic agentTubes (components)X-ray crystallographyการจำลองพลวัตเชิงโมเลกุลตัวยับยั้งไวรัสเดงกี่ไวรัสภูมิคุ้มกันบกพร่องในแมวสังคมสูงอายุสารต้านมาลาเรียสารต้านไวรัสสารไล่ยุงสารสกัดจากเห็ดสารออกฤทธิ์สารออกฤทธิ์ทางชีวภาพสารออกฤทธิ์ทางชีวภาพ สมุนไพร ยารักษาโรคเห็ดเห็ดและราขนาดใหญ่ออกแบบโครงสร้างเอ็นเอส 3 โปรตีเอสไฮโดรเจล

    Interest

    Computer-Aided Drug Design, Virtual Screening, Molecular Docking

    Resource

    • จำนวนหน่วยปฏิบัติการที่เข้าร่วม 0 หน่วย
    • จำนวนเครื่องมือวิจัย 0 ชิ้น

    งานวิจัยในรอบ 5 ปี

    Project

    งานวิจัยที่อยู่ระหว่างการดำเนินการ
    • ทุนใน 6 โครงการ (หัวหน้าโครงการ 4 โครงการ, หัวหน้าโครงการย่อย 2 โครงการ)
    • ทุนนอก 0 โครงการ
    งานวิจัยที่เสร็จสิ้นแล้ว
    • ทุนใน 8 โครงการ (หัวหน้าโครงการ 4 โครงการ, ผู้ร่วมวิจัย 2 โครงการ, หัวหน้าโครงการย่อย 2 โครงการ)
    • ทุนนอก 7 โครงการ (หัวหน้าโครงการ 3 โครงการ, ผู้ร่วมวิจัย 4 โครงการ)

    แนวโน้มผลงานทั้งหมดเทียบกับแนวโน้มผลงานในรอบ 5 ปี

    Output

    • บทความ 127 เรื่อง (ตีพิมพ์ในวารสารวิชาการ 73 เรื่อง, นำเสนอในการประชุม/สัมมนา 54 เรื่อง)
    • ทรัพย์สินทางปัญญา 0 เรื่อง (ลิขสิทธิ์ 0 เรื่อง, เครื่องหมายการค้า 0 เรื่อง, อนุสิทธิบัตร 0 เรื่อง, สิทธิบัตร 0 เรื่อง)
    • สิ่งประดิษฐ์ 0 เรื่อง (ขึ้นทะเบียนพันธุ์พืช หรือพันธุ์สัตว์ หรือสิ่งประดิษฐ์ มก. 0 เรื่อง)
    • Unknown 0 เรื่อง (Unknown 0 เรื่อง)

    แนวโน้มการนำผลงานไปใช้ประโยชน์ในด้านต่างๆ

    Outcome

    • การนำผลงานไปใช้ประโยชน์ 18 เรื่อง (เชิงวิชาการ 17 เรื่อง, เชิงนโยบาย/บริหาร 0 เรื่อง, เชิงสาธารณะ 1 เรื่อง, เชิงพาณิชย์ 0 เรื่อง)

    รางวัลที่ได้รับ

    Award

    • รางวัลที่ได้รับ 2 เรื่อง (ประกาศเกียรติคุณ/รางวัลนักวิจัย 0 เรื่อง, รางวัลผลงานวิจัย/สิ่งประดิษฐ์ 2 เรื่อง, รางวัลผลงานนำเสนอในการประชุมวิชาการ 0 เรื่อง)

    นักวิจัยที่มีผลงานงานร่วมกันมากที่สุด 10 คนแรก


    Scopus h-index

    #Document titleAuthorsYearSourceCited by
    1Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sitesChanprapaph S., Saparpakorn P., Sangma C., Niyomrattanakit P., Hannongbua S., Angsuthanasombat C., Katzenmeier G.2005Biochemical and Biophysical Research Communications,
    330(4), pp. 1237-1246
    87
    2Molecular docking studies and anti-tyrosinase activity of thai mango seed kernel extractNithitanakool S., Pithayanukul P., Bavovada R., Saparpakorn P.2009Molecules,
    14(1), pp. 257-265
    60
    3Chaetoglobins A and B, two unusual alkaloids from endophytic Chaetomium globosum cultureMing Ge H., Yun Zhang W., Ding G., Saparpakorn P., Chun Song Y., Hannongbua S., Xiang Tan R.2008Chemical Communications,
    (45), pp. 5978-5980
    52
    4Investigating the structural basis of arylamides to improve potency against M. tuberculosis strain through molecular dynamics simulationsPunkvang A., Saparpakorn P., Hannongbua S., Wolschann P., Beyer A., Pungpo P.2010European Journal of Medicinal Chemistry,
    45(12), pp. 5585-5593
    52
    5Magnetic carbon nanofiber composite adsorbent through green in-situ conversion of bacterial cellulose for highly efficient removal of bisphenol AThaveemas P., Chuenchom L., Kaowphong S., Techasakul S., Saparpakorn P., Dechtrirat D., Dechtrirat D.2021Bioresource Technology,
    333, 125184
    51
    6Molecular docking studies and anti-enzymatic activities of thai mango seed kernel extract against snake venomsLeanpolchareanchai J., Pithayanukul P., Bavovada R., Saparpakorn P.2009Molecules,
    14(4), pp. 1404-1422
    47
    7Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray CrystallographyKamsri P., Hanwarinroj C., Phusi N., Pornprom T., Chayajarus K., Punkvang A., Suttipanta N., Srimanote P., Suttisintong K., Songsiriritthigul C., Saparpakorn P., Hannongbua S., Rattanabunyong S., Seetaha S., Choowongkomon K., Sureram S., Kittakoop P., Kittakoop P., Kittakoop P., Hongmanee P., Santanirand P., Chen Z., Zhu W., Blood R.A., Takebayashi Y., Hinchliffe P., Mulholland A.J., Spencer J., Pungpo P.2020Journal of Chemical Information and Modeling,
    60(1), pp. 226-234
    47
    8Molecular docking studies and anti-snake venom metalloproteinase activity of thai mango seed kernel extractPithayanukul P., Leanpolchareanchai J., Saparpakorn P.2009Molecules,
    14(9), pp. 3198-3213
    45
    9Camellia sinensis L. Extract and its potential beneficial effects in antioxidant, anti-inflammatory, anti-hepatotoxic, and anti-tyrosinase activitiesThitimuta S., Pithayanukul P., Nithitanakool S., Bavovada R., Leanpolchareanchai J., Saparpakorn P.2017Molecules,
    22(3), 401
    41
    10Molecular epidemiology of norovirus associated with gastroenteritis and emergence of norovirus GII.4 variant 2012 in Japanese pediatric patientsThongprachum A., Thongprachum A., Chan-it W., Khamrin P., Saparpakorn P., Okitsu S., Okitsu S., Takanashi S., Mizuguchi M., Hayakawa S., Maneekarn N., Ushijima H., Ushijima H.2014Infection, Genetics and Evolution,
    23, pp. 65-73
    38
    11A facile one-pot green synthesis of gold nanoparticle-graphene-PEDOT:PSS nanocomposite for selective electrochemical detection of dopaminePananon P., Sriprachuabwong C., Sriprachuabwong C., Wisitsoraat A., Chuysinuan P., Tuantranont A., Saparpakorn P., Dechtrirat D.2018RSC Advances,
    8(23), pp. 12724-12732
    34
    12Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM methodKitisripanya N., Kitisripanya N., Saparpakorn P., Wolschann P., Hannongbua S.2011Nanomedicine: Nanotechnology, Biology, and Medicine,
    7(1), pp. 60-68
    32
    13Synthesis and anti-acetylcholinesterase activity of scopoletin derivativesKhunnawutmanotham N., Chimnoi N., Saparpakorn P., Techasakul S., Techasakul S.2016Bioorganic Chemistry,
    65, pp. 137-145
    31
    14Investigation on the binding of polycyclic aromatic hydrocarbons with soil organic matter: A theoretical approachSaparpakorn P., Jae H., Hannongbua S.2007Molecules,
    12(4), pp. 703-715
    29
    15Understanding the effects of two bound glucose in Sudlow site I on structure and function of human serum albumin: theoretical studiesAwang T., Wiriyatanakorn N., Saparpakorn P., Japrung D., Pongprayoon P.2017Journal of Biomolecular Structure and Dynamics,
    35(4), pp. 781-790
    23
    16Chevalone C analogues and globoscinic acid derivatives from the fungus Neosartorya spinosa KKU-1NK1Rajachan O., Kanokmedhakul K., Sanmanoch W., Boonlue S., Hannongbua S., Saparpakorn P., Kanokmedhakul S.2016Phytochemistry,
    132, pp. 68-75
    21
    17Structure and Dynamics of SARS Coronavirus Proteinase: The Primary Key to the Designing and Screening for Anti-SARS DrugsLee V.S., Lee V.S., Wittayanarakul K., Remsungnen T., Parasuk V., Sompornpisut P., Chantratita W., Sangma C., Vannarat S., Srichaikul P., Hannongbua S., Saparpakorn P., Treesuwan W., Aruksakulwong O., Pasomsub E., Promsri S., Chuakheaw D., Hannongbua S.2003ScienceAsia,
    29(2), pp. 181-188
    20
    18Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculationsHonorio P., Sainimnuan S., Hannongbua S., Saparpakorn P.2021Chemico-Biological Interactions,
    344, 109523
    20
    19Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivativesPungpo P., Saparpakorn P., Wolschann P., Hannongbua S.2006SAR and QSAR in Environmental Research,
    17(4), pp. 353-370
    18
    20Adsorption study of lac dyes with chitosan coated on silk fibroin using molecular dynamics simulationsChimprasit A., Hannongbua S., Saparpakorn P.2021Journal of Molecular Graphics and Modelling,
    106, 107934
    17
    21Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosisPakamwong B., Thongdee P., Kamsri B., Phusi N., Kamsri P., Punkvang A., Ketrat S., Saparpakorn P., Hannongbua S., Ariyachaokun K., Suttisintong K., Sureram S., Kittakoop P., Kittakoop P., Kittakoop P., Hongmanee P., Santanirand P., Spencer J., Mulholland A.J., Pungpo P.2021Journal of Chemical Information and Modeling17
    22Rational design of InhA inhibitors in the class of diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulationsKamsri P., Koohatammakun N., Srisupan A., Meewong P., Punkvang A., Saparpakorn P., Hannongbua S., Wolschann P., Prueksaaroon S., Leartsakulpanich U., Pungpo P.2014SAR and QSAR in Environmental Research,
    25(6), pp. 473-488
    15
    23NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activitiesThammaporn R., Thammaporn R., Yagi-Utsumi M., Yagi-Utsumi M., Yamaguchi T., Yamaguchi T., Boonsri P., Saparpakorn P., Choowongkomon K., Techasakul S., Kato K., Kato K., Hannongbua S.2015Scientific Reports,
    5, 15806
    15
    24Insight into crucial inhibitor-enzyme interaction of arylamides as novel direct inhibitors of the enoyl ACP reductase (InhA) from Mycobacterium tuberculosis: Computer-aided molecular designPunkvang A., Saparpakorn P., Hannongbua S., Wolschann P., Berner H., Pungpo P.2010Monatshefte fur Chemie,
    141(9), pp. 1029-1041
    13
    25Particular interaction between pyrimethamine derivatives and quadruple mutant type dihydrofolate reductase of Plasmodium falciparum: CoMFA and quantum chemical calculations studiesMaitarad P., Saparpakorn P., Hannongbua S., Kamchonwongpaisan S., Tarnchompoo B., Yuthavong Y.2009Journal of Enzyme Inhibition and Medicinal Chemistry,
    24(2), pp. 471-479
    13
    26Insight into the structural requirements of aminopyrimidine derivatives for good potency against both purified enzyme and whole cells of M. tuberculosis: Combination of HQSAR, CoMSIA, and MD simulation studiesPunkvang A., Hannongbua S., Saparpakorn P., Pungpo P.2016Journal of Biomolecular Structure and Dynamics,
    34(5), pp. 1079-1091
    12
    27Terezine derivatives from the fungus Phoma herbarum PSU-H256Maha A., Rukachaisirikul V., Saithong S., Phongpaichit S., Poonsuwan W., Sakayaroj J., Saparpakorn P., Hannongbua S.2016Phytochemistry,
    122, pp. 223-229
    12
    28Elucidating drug-enzyme interactions and their structural basis for improving the affinity and potency of isoniazid and its derivatives based on computer modeling approachesPunkvang A., Saparpakorn P., Hannongbua S., Wolschann P., Pungpo P.2010Molecules,
    15(4), pp. 2791-2813
    12
    29A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheasMuangnil P., Satitsri S., Tadpetch K., Saparpakorn P., Chatsudthipong V., Hannongbua S., Rukachaisirikul V., Muanprasat C.2018Biochemical Pharmacology,
    150, pp. 293-304
    11
    30Elucidating structural basis of benzofuran pyrrolidine pyrazole derivatives for enhancing potency against both the InhA enzyme and intact M. tuberculosis cells: a combined MD simulations and 3D-QSAR studyKamsri P., Punkvang A., Hannongbua S., Saparpakorn P., Pungpo P.2015RSC Advances,
    5(65), pp. 52926-52937
    9
    31Synthesis of 3-aminocoumarin-N-benzylpyridinium conjugates with nanomolar inhibitory activity against acetylcholinesteraseKhunnawutmanotham N., Laongthipparos C., Saparpakorn P., Chimnoi N., Techasakul S.2018Beilstein Journal of Organic Chemistry,
    14, pp. 2545-2552
    9
    32In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictionsHanwarinroj C., Thongdee P., Sukchit D., Taveepanich S., Kamsri P., Punkvang A., Ketrat S., Saparpakorn P., Hannongbua S., Suttisintong K., Kittakoop P., Kittakoop P., Kittakoop P., Spencer J., Mulholland A.J., Pungpo P.2022Journal of Molecular Graphics and Modelling,
    115, 108231
    9
    33Structural analysis of the coronavirus main protease for the design of pan-variant inhibitorsRungruangmaitree R., Phoochaijaroen S., Chimprasit A., Saparpakorn P., Pootanakit K., Tanramluk D., Tanramluk D.2023Scientific Reports,
    13(1), 7055
    9
    34Structural basis for inhibition of a GH116 β-glucosidase and its missense mutants by GBA2 inhibitors: Crystallographic and quantum chemical studyMeelua W., Thinkumrob N., Saparpakorn P., Pengthaisong S., Hannongbua S., Ketudat Cairns J.R., Jitonnom J.2023Chemico-Biological Interactions,
    384, 110717
    8
    35Divide-and-conquer-based quantum chemical study for interaction between HIV-1 reverse transcriptase and MK-4965 inhibitorSaparpakorn P., Saparpakorn P., Kobayashi M., Kobayashi M., Hannongbua S., Nakai H., Nakai H.2013International Journal of Quantum Chemistry,
    113(4), pp. 510-517
    8
    36Recent advances in NNRTI design: Computer-aided molecular design approachesPungpo P., Punkvang A., Saparpakorn P., Wolschann P., Hannongbua S.2009Current Computer-Aided Drug Design,
    5(3), pp. 174-199
    8
    37Substrate induced structural and dynamics changes in human phosphomevalonate kinase and implications for mechanismOlson A.L., Yao H., Herdendorf T.J., Miziorko H.M., Hannongbua S., Saparpakorn P., Cai S., Sem D.S.2009Proteins: Structure, Function and Bioinformatics,
    75(1), pp. 127-138
    7
    38Exploring the molecular basis for selective cytotoxicity of lamellarins against human hormone-dependent T47D and hormone-independent MDA-MB-231 breast cancer cellsThipnate P., Chittchang M., Thasana N., Saparpakorn P., Ploypradith P., Hannongbua S.2011Monatshefte fur Chemie,
    142(1), pp. 97-109
    7
    39Novel 2-chloro-8-arylthiomethyldipyridodiazepinone derivatives with activity against HIV-1 reverse transcriptaseKhunnawutmanotham N., Chimnoi N., Saparpakorn P., Pungpo P., Louisirirotchanakul S., Hannongbua S., Techasakul S., Techasakul S.2007Molecules,
    12(2), pp. 218-230
    7
    40Design of nevirapine derivatives insensitive to the K103N and Y181C HIV-1 reverse transcriptase mutantsSaparpakorn P., Hannongbua S., Rognan D.2006SAR and QSAR in Environmental Research,
    17(2), pp. 183-194
    7
    41Alkali-treated starches as a new class of templates for CaCO3 spherulite formation: Experimental and theoretical studiesPrajongtat P., Saparpakorn P., Asamo S., Hongsprabhas P., Israkarn K., Israkarn K.2019Journal of Crystal Growth,
    522, pp. 45-52
    7
    42Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial ActivityThongdee P., Hanwarinroj C., Pakamwong B., Kamsri P., Punkvang A., Leanpolchareanchai J., Ketrat S., Saparpakorn P., Hannongbua S., Ariyachaokun K., Suttisintong K., Sureram S., Kittakoop P., Kittakoop P., Kittakoop P., Hongmanee P., Santanirand P., Mukamolova G.V., Blood R.A., Takebayashi Y., Spencer J., Mulholland A.J., Pungpo P.2022Journal of Chemical Information and Modeling6
    43Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics predictionHonorio P., Hannongbua S., Saparpakorn P.2022Chemico-Biological Interactions,
    368, 110227
    6
    443D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitorsJitonnom J., Meelua W., Tue-nguen P., Tue-nguen P., Saparpakorn P., Hannongbua S., Chotpatiwetchkul W.2024Chemico-Biological Interactions,
    396, 111040
    6
    45Combining Deep Learning and Structural Modeling to Identify Potential Acetylcholinesterase Inhibitors from Hericium erinaceusSutthibutpong T., Posansee K., Liangruksa M., Termsaithong T., Piyayotai S., Phitsuwan P., Saparpakorn P., Hannongbua S., Laomettachit T.2023ACS Omega5
    46Discovery of novel and potent InhA inhibitors by an in silico screening and pharmacokinetic predictionHanwarinroj C., Phusi N., Kamsri B., Kamsri P., Punkvang A., Ketrat S., Saparpakorn P., Hannongbua S., Suttisintong K., Kittakoop P., Kittakoop P., Kittakoop P., Spencer J., Mulholland A.J., Pungpo P.2022Future Medicinal Chemistry,
    14(10), pp. 717-729
    5
    47Combined Deep Learning and Molecular Modeling Techniques on the Virtual Screening of New mTOR Inhibitors from the Thai Mushroom DatabasePosansee K., Liangruksa M., Termsaithong T., Saparpakorn P., Hannongbua S., Laomettachit T., Sutthibutpong T.2023ACS Omega5
    48Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase ActivityKamsri B., Pakamwong B., Thongdee P., Phusi N., Kamsri P., Punkvang A., Ketrat S., Saparpakorn P., Hannongbua S., Sangswan J., Suttisintong K., Sureram S., Kittakoop P., Kittakoop P., Kittakoop P., Hongmanee P., Santanirand P., Leanpolchareanchai J., Goudar K.E., Spencer J., Mulholland A.J., Pungpo P.2022Journal of Chemical Information and Modeling5
    49Investigating the binding affinities of fructose and galactose to human serum albumin: simulation studiesAwang T., Niramitranon J., Japrung D., Saparpakorn P., Pongprayoon P.2021Molecular Simulation5
    50Elucidating the structural basis of diphenyl ether derivatives as highly potent enoyl-ACP reductase inhibitors through molecular dynamics simulations and 3D-QSAR studyKamsri P., Punkvang A., Saparpakorn P., Hannongbua S., Irle S., Pungpo P.2014Journal of Molecular Modeling,
    20(7), 2319
    5
    51Dipyridodiazepinone derivatives; synthesis and anti HIV-1 activityKhunnawutmanotham N., Chimnoi N., Thitithanyanont A., Saparpakorn P., Choowongkomon K., Pungpo P., Hannongbua S., Techasakul S., Techasakul S.2009Beilstein Journal of Organic Chemistry,
    5, A36
    4
    52Use of 3D QSAR to investigate the mode of binding of pyrazinones to HIV-1 RTSaparpakorn P., Thammaporn R., Hannongbua S.2009Monatshefte fur Chemie,
    140(6), pp. 587-594
    4
    53Divide-and-conquer electronic-structure study on the mechanism of the west nile virus NS3 protease inhibitorSaparpakorn P., Saparpakorn P., Kobayashi M., Kobayashi M., Nakai H., Nakai H.2013Bulletin of the Chemical Society of Japan,
    86(1), pp. 67-74
    4
    54New potent epitopes from Leptospira borgpetersenii for the stimulation of humoral and cell-mediated immune responses: Experimental and theoretical studiesTansiri Y., Tansiri Y., Sritrakul T., Saparpakorn P., Boondamnern T., Chimprasit A., Sripattanakul S., Hannongbua S., Prapong S., Prapong S.2021Informatics in Medicine Unlocked,
    25, 100649
    3
    55Crystal structure of 5-[(benzoyloxy)methyl]-5,6- dihydroxy-4-oxocyclohex-2-en-1-yl benzoateLeepasert T., Saparpakorn P., Chainok K., Duangthongyou T.2020Acta Crystallographica Section E: Crystallographic Communications,
    76, pp. 1096-1100
    3
    56Systematic investigation on the binding of GW420867X as HIV-1 reverse transcriptase inhibitorSaparpakorn P., Saparpakorn P., Wolschann P., Karpfen A., Pungpo P., Hannongbua S.2011Monatshefte fur Chemie,
    142(9), pp. 961-971
    3
    57Key structural features of azanaphthoquinone annelated pyrrole derivative as anticancer agents based on the rational drug design approachesKamsri P., Punkvang A., Pongprom N., Srisupan A., Saparpakorn P., Hannongbua S., Wolschann P., Pungpo P.2013Molecular Informatics,
    32(5-6), pp. 541-554
    3
    58Theoretical study on the selective fluorescence of PicoGreen: Binding models and photophysical propertiesOkoshi M., Saparpakorn P., Takada Y., Hannongbua S., Nakai H., Nakai H., Nakai H.2014Bulletin of the Chemical Society of Japan,
    87(2), pp. 267-273
    3
    59Key structures and interactions for binding of mycobacterium tuberculosis protein kinase B inhibitors from molecular dynamics simulationPunkvang A., Kamsri P., Saparpakorn P., Hannongbua S., Wolschann P., Irle S., Pungpo P.2015Chemical Biology and Drug Design,
    86(1), pp. 871-881
    2
    60Anticodon-binding domain swapping in a nondiscriminating aspartyl-tRNA synthetase reveals contributions to tRNA specificity and catalytic activityChuawong P., Likittrakulwong W., Likittrakulwong W., Suebka S., Suebka S., Wiriyatanakorn N., Saparpakorn P., Taweesablamlert A., Sudprasert W., Hendrickson T., Svasti J.2020Proteins: Structure, Function and Bioinformatics,
    88(9), pp. 1133-1142
    2
    61Insight investigation of rilpivirine and compounds from mushrooms as feline immunodeficiency virus reverse transcriptase inhibitors using molecular dynamics simulations and quantum chemical calculationsSaparpakorn P., Chimprasit A., Jantarat T., Hannongbua S.2022Molecular Simulation2
    62Diptoindonesin D, a potent antibacterial activity against gram-positive bacteria, an inhibitor of penicillin-binding protein 2a from the stem bark of Shorea roxburghii G.DonSudto K., Saparpakorn P., Saparpakorn P., Tancharoen C., Tancharoen C., Phromyothin D., Techasakul S., Khunnawutmanotham N., Vajrodaya S., Ge H.M., Tan R.X., Tan R.X., Hannongbua S.2019Chiang Mai Journal of Science,
    46(6), pp. 1161-1175
    2
    63Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2Chong W.L., Chong W.L., Saparpakorn P., Sangma C., Lee V.S., Hannongbua S.2023Heliyon,
    9(1), e12667
    2
    64Synthesis and Acetylcholinesterase Inhibitory Evaluation of Coumarin-Linked Carbazole DerivativesTharamak S., Wisarutwanit T., Songoen W., Saparpakorn P., Pluempanupat W.2023ChemistrySelect,
    8(46), e202303879
    2
    65Synthesis, Antiacetylcholinesterase Activity, and Molecular Dynamics Simulation of Aporphine-benzylpyridinium ConjugatesKhunnawutmanotham N., Sooknual P., Batsomboon P., Ploypradith P., Ploypradith P., Chimnoi N., Patigo A., Saparpakorn P., Techasakul S.2023ACS Medicinal Chemistry Letters2
    66Signal Propagation in the ATPase Domain of Mycobacterium tuberculosis DNA Gyrase from Dynamical-Nonequilibrium Molecular Dynamics SimulationsKamsri B., Kamsri P., Punkvang A., Chimprasit A., Saparpakorn P., Hannongbua S., Spencer J., Oliveira A.S.F., Mulholland A.J., Pungpo P.2024Biochemistry2
    67Calcium transport across intestinal epithelia depends on voltage-gated sodium channels and endocannabinoid systemThammayon N., Wongdee K., Teerapornpuntakit J., Teerapornpuntakit J., Jantarajit W., Panmanee J., Patigo A., Saparpakorn P., Tanramluk D., Tanramluk D., Charoenphandhu N., Charoenphandhu N., Charoenphandhu N.2025Biochemical and Biophysical Research Communications,
    758, 151635
    1
    68Key interactions of pyrimethamine derivatives specific to wild-type and mutant P. falciparum dihydrofolate reductase based on 3D-QSAR, MD simulations and quantum chemical calculationsSeetin S., Saparpakorn P., Vanichtanankul J., Vitsupakorn D., Yuthavong Y., Kamchonwongpaisan S., Hannongbua S.2022Journal of Biomolecular Structure and Dynamics1
    69In silico multiscale drug design to discover key structural features of potential JAK2 inhibitorsKamsri P., Punkvang A., Taveepanich S., Ketrat S., Saparpakorn P., Hannongbua S., Suttisintong K., Pangjit K., Pungpo P.2022Future medicinal chemistry,
    14(18), pp. 1297-1308
    1
    70Molecular dynamics simulations of azanaphthoquinone annelated pyrrole derivatives as anticancer agent in DNA duplexPunkvang A., Pungpo P., Kamsri P., Kasamsri D., Srisupan A., Saparpakorn P., Hannongbua S., Wolschann P., Prueksaaroon S., Pongprom N.2013International Journal of Quantum Chemistry,
    113(4), pp. 555-562
    1
    71Elucidating the action mode of the bi-substrate inhainhibitors as anti-tuberculosis agents through molecular dynamics simulationsPunkvang A., Kamsri P., Kasamsri D., Srisupan A., Saparpakorn P., Hannongbua S., Wolschann P., Prueksaaroon S., Pungpo P.2012Tuberculosis: Risk Factors, Drug Resistance and Treatment,
    pp. 169-180
    0
    72Torsional flexibility of undecorated catechol diether compound as potent NNRTI targeting HIV-1 reverse transcriptaseSomboon T., Saparpakorn P., Hannongbua S.2019Journal of Molecular Graphics and Modelling,
    86, pp. 286-297
    0
    73Predicting the binding affinity of p38 map kinase inhibitors using free energy calculationsBoonyarat W., Saparpakorn P., Hannongbua S.2019Chiang Mai Journal of Science,
    46(1), pp. 93-105
    0
    74Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADME Predictions of Huperzine: A Derivative for the Novel Protective Application Against NeurodegenerationsHomkajorn B., Nilsu T., Suntararuks S., Saparpakorn P., Ingkaninan K., Limpeanchob N., Satayavivad J., Satayavivad J., Ruchirawat S., Ruchirawat S., Ruchirawat S., Thasana N., Thasana N., Thasana N.2025Chemistry - An Asian Journal0
    75Synthesis of (−)-8a-epi-Lentiginosine via Tsuji–Trost Reaction of d-Glucose-Derived Allylic Alcohols and Crystal Structure AnalysisAkkarasamiyo S., Saparpakorn P., Orthaber A., Samec J.S.M.2025Asian Journal of Organic Chemistry0
    76Role of interaction mode of phenanthrene derivatives as selective PDE5 inhibitors using molecular dynamics simulations and quantum chemical calculationsSainimnuan S., Chimprasit A., Hannongbua S., Saparpakorn P.2024Molecular Diversity,
    111527
    0
    77Elucidation of benzene sulfonamide derivative binding at a novel interprotomer pocket of wild type and mutants of coxsackievirus B3 viral capsid using molecular dynamics simulations and density functional theoryPrapassornwattana P., Hannongbua S., Saparpakorn P.2023Biophysical Chemistry,
    302, 107109
    0